10 20 30 40 50 60 70 80 1OJW - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER REGULATOR OF COMPLEMENT PATHWAY 16-JUL-03 1OJW
TITLE DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN TITLE 2 INTACT HUMAN COMPLEMENT REGULATOR.
COMPND MOL_ID: 1; COMPND 2 MOLECULE: COMPLEMENT DECAY-ACCELERATING FACTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: FOUR EXTRACELLULAR SCR DOMAINS RESIDUES 35-285; COMPND 5 SYNONYM: CD55, DAF; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: MODELLED GLYCEROLS AND SULPHATES FROM COMPND 8 CRYSTALLISATION BUFFER
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 OTHER_DETAILS: HUMAN SEQUENCE EXPRESSED IN E.COLI.
KEYWDS REGULATOR OF COMPLEMENT PATHWAY, REGULATOR OF COMPLEMENT, KEYWDS 2 DECAY ACCELERATION OF C3/C5 CONVERTASES, PATHOGEN KEYWDS 3 RECEPTOR, SHORT CONSENSUS REPEAT DOMAINS
EXPDTA X-RAY DIFFRACTION
AUTHOR P.LUKACIK,P.ROVERSI,J.WHITE,D.ESSER,G.P.SMITH,J.BILLINGTON, AUTHOR 2 P.A.WILLIAMS,P.M.RUDD,M.R.WORMALD,M.D.M.CRISPIN, AUTHOR 3 C.M.RADCLIFFE,C.M.DWEK,D.J.EVANS,B.P.MORGAN,R.A.G.SMITH, AUTHOR 4 S.M.LEA
REVDAT 4 24-FEB-09 1OJW 1 VERSN REVDAT 3 26-AUG-04 1OJW 1 REMARK REVDAT 2 12-FEB-04 1OJW 1 JRNL REVDAT 1 07-JAN-04 1OJW 0
JRNL AUTH P.LUKACIK,P.ROVERSI,J.WHITE,D.ESSER,G.P.SMITH, JRNL AUTH 2 J.BILLINGTON,P.A.WILLIAMS,P.M.RUDD,M.R.WORMALD, JRNL AUTH 3 D.J.HARVEY,M.D.M.CRISPIN,C.M.RADCLIFFE,R.A.DWEK, JRNL AUTH 4 D.J.EVANS,B.P.MORGAN,R.A.G.SMITH,S.M.LEA JRNL TITL COMPLEMENT REGULATION AT THE MOLECULAR LEVEL: THE JRNL TITL 2 STRUCTURE OF DECAY-ACCELERATING FACTOR JRNL REF PROC.NATL.ACAD.SCI.USA V. 101 1279 2004 JRNL REFN ISSN 0027-8424 JRNL PMID 14734808 JRNL DOI 10.1073/PNAS.0307200101
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.WHITE,P.LUKACIK,D.ESSER,M.STEWARD,N.GIDDINGS, REMARK 1 AUTH 2 J.R.BRIGHT,S.FRITCHLEY,B.P.MORGAN,S.M.LEA, REMARK 1 AUTH 3 G.P.SMITH,R.A.G.SMITH REMARK 1 TITL BIOLOGICAL ACTIVITY, MEMBRANE-TARGETING REMARK 1 TITL 2 MODIFICATION, AND CRYSTALLIZATION OF SOLUBLE HUMAN REMARK 1 TITL 3 DECAY ACCELERATING FACTOR EXPRESSED IN E. COLI REMARK 1 REF PROTEIN SCI. V. 13 2406 2004 REMARK 1 REFN ISSN 0961-8368 REMARK 1 PMID 15322283 REMARK 1 DOI 10.1110/PS.03455604
REMARK 2 REMARK 2 RESOLUTION. 2.3 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT 5F REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.3 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.0 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.0 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 14560 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : RANDOM REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.254 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.253 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 740 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 14560 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3901 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 22 REMARK 3 SOLVENT ATOMS : 33 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : 16.0 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.005 ; 2.0 ; 4041 REMARK 3 BOND ANGLES (DEGREES) : 0.608 ; 3.0 ; 5458 REMARK 3 TORSION ANGLES (DEGREES) : 20.99 ; 0.0 ; 2360 REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : 0.008 ; 2.0 ; 105 REMARK 3 GENERAL PLANES (A) : 0.012 ; 5.0 ; 577 REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : 2.715 ; 20.0 ; 4041 REMARK 3 NON-BONDED CONTACTS (A) : 0.126 ; 3.0 ; 132 REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : 0 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : BABINET SCALING REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 70 REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : TNT PROTGEO REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : TN BCORREL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BUSTER-TNT MAXIMUM LIKELIHOOD REMARK 3 REFINEMENT
REMARK 4 REMARK 4 1OJW COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-JUL-03. REMARK 100 THE PDBE ID CODE IS EBI-12932.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUL-01 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.60 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14573 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 6.370 REMARK 200 R MERGE (I) : 0.13500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.3700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.38800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.430 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: MOLREP, BUSTER, TNT, SHARP, DMMULTI, SOLOMON, REMARK 200 SIGMAA REMARK 200 STARTING MODEL: PDB ENTRY 1H03 REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM SULPHATE REMARK 280 20% M-PEG 5K, 0.1M SODIUM ACETATE PH 4.6 REMARK 280 10% GLYCEROL
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 CYS A 254 REMARK 465 MET B 1 REMARK 465 GLN B 2 REMARK 465 CYS B 254
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 250 - CZ ARG A 252 2.15 REMARK 500 OE2 GLU A 250 - NH1 ARG A 252 2.17 REMARK 500 OE2 GLU A 250 - NH2 ARG A 252 1.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 REMARK 500 OG1 THR B 121 OD2 ASP B 200 1665 2.09 REMARK 500 OD2 ASP B 200 OG1 THR B 121 1445 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 250 CD GLU A 250 OE2 -0.092 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 8 172.31 -58.40 REMARK 500 ASP A 26 -19.54 86.32 REMARK 500 LEU A 50 -157.21 -107.13 REMARK 500 SER A 56 -178.51 -62.19 REMARK 500 GLU A 60 124.59 -35.57 REMARK 500 LEU A 77 158.80 -49.16 REMARK 500 ASN A 85 -16.94 -151.61 REMARK 500 PHE A 87 73.84 -104.74 REMARK 500 PRO A 105 -54.06 -21.77 REMARK 500 LEU A 117 61.79 64.53 REMARK 500 VAL A 123 -158.17 -87.67 REMARK 500 VAL A 144 79.59 -103.89 REMARK 500 GLU A 207 -149.21 -48.26 REMARK 500 ARG A 214 -1.30 73.66 REMARK 500 ASN A 239 54.43 71.33 REMARK 500 ASP A 240 19.68 52.41 REMARK 500 CYS A 251 78.57 -110.55 REMARK 500 ASP B 26 -15.67 78.78 REMARK 500 ILE B 58 132.92 179.15 REMARK 500 LEU B 77 156.62 -48.96 REMARK 500 ASN B 85 -20.59 -145.08 REMARK 500 PHE B 87 66.71 -112.70 REMARK 500 ARG B 98 -158.11 -80.02 REMARK 500 PRO B 105 -49.04 -27.55 REMARK 500 VAL B 123 -159.22 -81.60 REMARK 500 VAL B 144 77.84 -103.88 REMARK 500 SER B 178 174.75 175.55 REMARK 500 PRO B 186 -172.58 -58.46 REMARK 500 ARG B 214 -20.38 74.15 REMARK 500 ASN B 239 56.51 71.92 REMARK 500 ASP B 240 16.10 53.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 LEU A 114 24.8 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A1254 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A1255 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A1256 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A1257
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1H03 RELATED DB: PDB REMARK 900 HUMAN CD55 DOMAINS 3 & 4 REMARK 900 RELATED ID: 1H04 RELATED DB: PDB REMARK 900 HUMAN CD55 DOMAINS 3 & 4 REMARK 900 RELATED ID: 1H2P RELATED DB: PDB REMARK 900 HUMAN CD55 DOMAINS 3 & 4 REMARK 900 RELATED ID: 1H2Q RELATED DB: PDB REMARK 900 HUMAN CD55 DOMAINS 3 & 4 REMARK 900 RELATED ID: 1M11 RELATED DB: PDB REMARK 900 STRUCTURAL MODEL OF HUMAN DECAY-ACCELERATING REMARK 900 FACTOR BOUNDTO ECHOVIRUS 7 FROM CRYO- REMARK 900 ELECTRON MICROSCOPY REMARK 900 RELATED ID: 1NWV RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF A FUNCTIONALLY ACTIVE REMARK 900 COMPONENT OFDECAY ACCELERATING FACTOR REMARK 900 RELATED ID: 1OJV RELATED DB: PDB REMARK 900 DECAY ACCELERATING FACTOR: THE STRUCTURE OF REMARK 900 AN INTACT HUMAN COMPLEMENT REGULATOR. REMARK 900 RELATED ID: 1OJY RELATED DB: PDB REMARK 900 DECAY ACCELERATING FACTOR: THE STRUCTURE OF REMARK 900 AN INTACT HUMAN COMPLEMENT REGULATOR. REMARK 900 RELATED ID: 1OK1 RELATED DB: PDB REMARK 900 DECAY ACCELERATING FACTOR: THE STRUCTURE OF REMARK 900 AN INTACT HUMAN COMPLEMENT REGULATOR. REMARK 900 RELATED ID: 1OK2 RELATED DB: PDB REMARK 900 DECAY ACCELERATING FACTOR: THE STRUCTURE OF REMARK 900 AN INTACT HUMAN COMPLEMENT REGULATOR. REMARK 900 RELATED ID: 1OK3 RELATED DB: PDB REMARK 900 DECAY ACCELERATING FACTOR: THE STRUCTURE OF REMARK 900 AN INTACT HUMAN COMPLEMENT REGULATOR. REMARK 900 RELATED ID: 1OK9 RELATED DB: PDB REMARK 900 DECAY ACCELERATING FACTOR: THE STRUCTURE OF REMARK 900 AN INTACT HUMAN COMPLEMENT REGULATOR. REMARK 900 RELATED ID: 1UOT RELATED DB: PDB REMARK 900 HUMAN CD55 DOMAINS 3 & 4 REMARK 900 RELATED ID: 1UPN RELATED DB: PDB REMARK 900 COMPLEX OF ECHOVIRUS TYPE 12 WITH DOMAINS REMARK 900 3 AND 4 OF ITS RECEPTOR DECAY ACCELERATING REMARK 900 FACTOR (CD55) BY CRYO ELECTRON MICROSCOPY REMARK 900 AT 16 A
REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUES A48 AND B48 MAP ONTO RESIDUE 80 OF SWISSPROT ENTRY REMARK 999 P08174. RESIDUE 80 IN THE SWISSPROT ENTRY IS GIVEN AS THR, REMARK 999 BUT SOME REFERENCES FOR SWS P08174 SHOW RESIDUE 80 AS ILE. REMARK 999 THE RESIDUE IS ANNOTATED AS A CONFLICT IN THE SWS ENTRY AS REMARK 999 OF 16-07-2003
DBREF 1OJW A 1 2 PDB 1OJW 1OJW 1 2 DBREF 1OJW A 3 253 UNP P08174 DAF_HUMAN 35 285 DBREF 1OJW A 254 254 PDB 1OJW 1OJW 254 254 DBREF 1OJW B 1 2 PDB 1OJW 1OJW 1 2 DBREF 1OJW B 3 253 UNP P08174 DAF_HUMAN 35 285 DBREF 1OJW B 254 254 PDB 1OJW 1OJW 254 254
SEQADV 1OJW ILE A 48 UNP P08174 THR 80 SEE REMARK 999 SEQADV 1OJW ILE B 48 UNP P08174 THR 80 SEE REMARK 999
SEQRES 1 A 254 MET GLN ASP CYS GLY LEU PRO PRO ASP VAL PRO ASN ALA SEQRES 2 A 254 GLN PRO ALA LEU GLU GLY ARG THR SER PHE PRO GLU ASP SEQRES 3 A 254 THR VAL ILE THR TYR LYS CYS GLU GLU SER PHE VAL LYS SEQRES 4 A 254 ILE PRO GLY GLU LYS ASP SER VAL ILE CYS LEU LYS GLY SEQRES 5 A 254 SER GLN TRP SER ASP ILE GLU GLU PHE CYS ASN ARG SER SEQRES 6 A 254 CYS GLU VAL PRO THR ARG LEU ASN SER ALA SER LEU LYS SEQRES 7 A 254 GLN PRO TYR ILE THR GLN ASN TYR PHE PRO VAL GLY THR SEQRES 8 A 254 VAL VAL GLU TYR GLU CYS ARG PRO GLY TYR ARG ARG GLU SEQRES 9 A 254 PRO SER LEU SER PRO LYS LEU THR CYS LEU GLN ASN LEU SEQRES 10 A 254 LYS TRP SER THR ALA VAL GLU PHE CYS LYS LYS LYS SER SEQRES 11 A 254 CYS PRO ASN PRO GLY GLU ILE ARG ASN GLY GLN ILE ASP SEQRES 12 A 254 VAL PRO GLY GLY ILE LEU PHE GLY ALA THR ILE SER PHE SEQRES 13 A 254 SER CYS ASN THR GLY TYR LYS LEU PHE GLY SER THR SER SEQRES 14 A 254 SER PHE CYS LEU ILE SER GLY SER SER VAL GLN TRP SER SEQRES 15 A 254 ASP PRO LEU PRO GLU CYS ARG GLU ILE TYR CYS PRO ALA SEQRES 16 A 254 PRO PRO GLN ILE ASP ASN GLY ILE ILE GLN GLY GLU ARG SEQRES 17 A 254 ASP HIS TYR GLY TYR ARG GLN SER VAL THR TYR ALA CYS SEQRES 18 A 254 ASN LYS GLY PHE THR MET ILE GLY GLU HIS SER ILE TYR SEQRES 19 A 254 CYS THR VAL ASN ASN ASP GLU GLY GLU TRP SER GLY PRO SEQRES 20 A 254 PRO PRO GLU CYS ARG GLY CYS SEQRES 1 B 254 MET GLN ASP CYS GLY LEU PRO PRO ASP VAL PRO ASN ALA SEQRES 2 B 254 GLN PRO ALA LEU GLU GLY ARG THR SER PHE PRO GLU ASP SEQRES 3 B 254 THR VAL ILE THR TYR LYS CYS GLU GLU SER PHE VAL LYS SEQRES 4 B 254 ILE PRO GLY GLU LYS ASP SER VAL ILE CYS LEU LYS GLY SEQRES 5 B 254 SER GLN TRP SER ASP ILE GLU GLU PHE CYS ASN ARG SER SEQRES 6 B 254 CYS GLU VAL PRO THR ARG LEU ASN SER ALA SER LEU LYS SEQRES 7 B 254 GLN PRO TYR ILE THR GLN ASN TYR PHE PRO VAL GLY THR SEQRES 8 B 254 VAL VAL GLU TYR GLU CYS ARG PRO GLY TYR ARG ARG GLU SEQRES 9 B 254 PRO SER LEU SER PRO LYS LEU THR CYS LEU GLN ASN LEU SEQRES 10 B 254 LYS TRP SER THR ALA VAL GLU PHE CYS LYS LYS LYS SER SEQRES 11 B 254 CYS PRO ASN PRO GLY GLU ILE ARG ASN GLY GLN ILE ASP SEQRES 12 B 254 VAL PRO GLY GLY ILE LEU PHE GLY ALA THR ILE SER PHE SEQRES 13 B 254 SER CYS ASN THR GLY TYR LYS LEU PHE GLY SER THR SER SEQRES 14 B 254 SER PHE CYS LEU ILE SER GLY SER SER VAL GLN TRP SER SEQRES 15 B 254 ASP PRO LEU PRO GLU CYS ARG GLU ILE TYR CYS PRO ALA SEQRES 16 B 254 PRO PRO GLN ILE ASP ASN GLY ILE ILE GLN GLY GLU ARG SEQRES 17 B 254 ASP HIS TYR GLY TYR ARG GLN SER VAL THR TYR ALA CYS SEQRES 18 B 254 ASN LYS GLY PHE THR MET ILE GLY GLU HIS SER ILE TYR SEQRES 19 B 254 CYS THR VAL ASN ASN ASP GLU GLY GLU TRP SER GLY PRO SEQRES 20 B 254 PRO PRO GLU CYS ARG GLY CYS
HET SO4 A1254 5 HET SO4 A1255 5 HET GOL A1256 6 HET GOL A1257 6
HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL
FORMUL 3 SO4 2(O4 S 2-) FORMUL 5 GOL 2(C3 H8 O3) FORMUL 7 HOH *33(H2 O1)
HELIX 1 1 PRO A 80 GLN A 84 5 5 HELIX 2 2 PRO B 80 GLN B 84 5 5
SHEET 1 AA 4 ALA A 13 PRO A 15 0 SHEET 2 AA 4 VAL A 28 CYS A 33 -1 O LYS A 32 N GLN A 14 SHEET 3 AA 4 SER A 46 LEU A 50 -1 O VAL A 47 N ILE A 29 SHEET 4 AA 4 GLN A 54 TRP A 55 -1 O GLN A 54 N LEU A 50 SHEET 1 AB 3 PHE A 37 LYS A 39 0 SHEET 2 AB 3 CYS A 62 CYS A 66 -1 O ASN A 63 N VAL A 38 SHEET 3 AB 3 PHE A 87 PRO A 88 -1 O PHE A 87 N CYS A 66 SHEET 1 AC 3 ALA A 75 LEU A 77 0 SHEET 2 AC 3 VAL A 92 CYS A 97 -1 O GLU A 96 N SER A 76 SHEET 3 AC 3 LYS A 110 THR A 112 -1 O LEU A 111 N VAL A 93 SHEET 1 AD 2 TYR A 101 ARG A 103 0 SHEET 2 AD 2 CYS A 126 LYS A 128 -1 O LYS A 127 N ARG A 102 SHEET 1 AE 4 GLY A 140 ASP A 143 0 SHEET 2 AE 4 THR A 153 CYS A 158 -1 O SER A 155 N ASP A 143 SHEET 3 AE 4 SER A 169 ILE A 174 -1 O SER A 170 N ILE A 154 SHEET 4 AE 4 VAL A 179 TRP A 181 -1 O GLN A 180 N LEU A 173 SHEET 1 AF 2 TYR A 162 PHE A 165 0 SHEET 2 AF 2 GLU A 187 GLU A 190 -1 O GLU A 187 N PHE A 165 SHEET 1 AG 4 GLY A 202 ILE A 204 0 SHEET 2 AG 4 SER A 216 CYS A 221 -1 O ALA A 220 N ILE A 203 SHEET 3 AG 4 SER A 232 VAL A 237 -1 O ILE A 233 N VAL A 217 SHEET 4 AG 4 GLY A 242 TRP A 244 -1 O GLU A 243 N THR A 236 SHEET 1 AH 6 GLU A 250 ARG A 252 0 SHEET 2 AH 6 THR A 226 GLU A 230 -1 O THR A 226 N ARG A 252 SHEET 3 AH 6 GLY B 140 VAL B 144 -1 O VAL B 144 N GLY A 229 SHEET 4 AH 6 THR B 153 CYS B 158 -1 O SER B 155 N ASP B 143 SHEET 5 AH 6 SER B 169 SER B 175 -1 O SER B 170 N ILE B 154 SHEET 6 AH 6 SER B 178 TRP B 181 -1 O SER B 178 N SER B 175 SHEET 1 BA 4 ALA B 13 PRO B 15 0 SHEET 2 BA 4 VAL B 28 CYS B 33 -1 O LYS B 32 N GLN B 14 SHEET 3 BA 4 SER B 46 LEU B 50 -1 O VAL B 47 N ILE B 29 SHEET 4 BA 4 GLN B 54 TRP B 55 -1 O GLN B 54 N LEU B 50 SHEET 1 BB 2 PHE B 37 LYS B 39 0 SHEET 2 BB 2 CYS B 62 ARG B 64 -1 O ASN B 63 N VAL B 38 SHEET 1 BC 3 ALA B 75 LEU B 77 0 SHEET 2 BC 3 VAL B 92 CYS B 97 -1 O GLU B 96 N SER B 76 SHEET 3 BC 3 LYS B 110 THR B 112 -1 O LEU B 111 N VAL B 93 SHEET 1 BD 2 TYR B 101 ARG B 103 0 SHEET 2 BD 2 CYS B 126 LYS B 128 -1 O LYS B 127 N ARG B 102 SHEET 1 BE 2 TYR B 162 PHE B 165 0 SHEET 2 BE 2 GLU B 187 GLU B 190 -1 O GLU B 187 N PHE B 165 SHEET 1 BF 4 GLY B 202 GLN B 205 0 SHEET 2 BF 4 SER B 216 CYS B 221 -1 O THR B 218 N GLN B 205 SHEET 3 BF 4 SER B 232 VAL B 237 -1 O ILE B 233 N VAL B 217 SHEET 4 BF 4 GLY B 242 TRP B 244 -1 O GLU B 243 N THR B 236 SHEET 1 BG 2 THR B 226 ILE B 228 0 SHEET 2 BG 2 GLU B 250 ARG B 252 -1 O GLU B 250 N ILE B 228
SSBOND 1 CYS A 4 CYS A 49 1555 1555 2.04 SSBOND 2 CYS A 33 CYS A 62 1555 1555 2.03 SSBOND 3 CYS A 66 CYS A 113 1555 1555 2.02 SSBOND 4 CYS A 97 CYS A 126 1555 1555 2.03 SSBOND 5 CYS A 131 CYS A 172 1555 1555 2.03 SSBOND 6 CYS A 158 CYS A 188 1555 1555 2.03 SSBOND 7 CYS A 193 CYS A 235 1555 1555 2.03 SSBOND 8 CYS A 221 CYS A 251 1555 1555 2.03 SSBOND 9 CYS B 4 CYS B 49 1555 1555 2.03 SSBOND 10 CYS B 33 CYS B 62 1555 1555 2.03 SSBOND 11 CYS B 66 CYS B 113 1555 1555 2.03 SSBOND 12 CYS B 97 CYS B 126 1555 1555 2.03 SSBOND 13 CYS B 131 CYS B 172 1555 1555 2.03 SSBOND 14 CYS B 158 CYS B 188 1555 1555 2.03 SSBOND 15 CYS B 193 CYS B 235 1555 1555 2.04 SSBOND 16 CYS B 221 CYS B 251 1555 1555 2.03
CISPEP 1 GLN A 79 PRO A 80 0 4.50 CISPEP 2 PRO A 99 GLY A 100 0 1.91 CISPEP 3 GLN B 79 PRO B 80 0 5.10 CISPEP 4 PRO B 99 GLY B 100 0 1.59
SITE 1 AC1 5 TYR A 213 ARG A 214 THR A 236 TYR B 213 SITE 2 AC1 5 ARG B 214 SITE 1 AC2 2 GLN A 215 ARG B 138 SITE 1 AC3 6 CYS A 4 GLY A 5 LEU A 6 PRO A 8 SITE 2 AC3 6 SER A 53 TRP A 55 SITE 1 AC4 1 LYS B 78
CRYST1 53.099 51.892 64.125 78.39 83.66 63.22 P 1 2
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.018833 -0.009505 -0.000477 0.00000
SCALE2 0.000000 0.021586 -0.003740 0.00000
SCALE3 0.000000 0.000000 0.015924 0.00000